Online Database of Chemicals from Around the World

N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide
[CAS# 219766-25-3]

List of Suppliers
Taizhou Crene Biotechnology Co., Ltd. China Inquire  
+86 (576) 8881-3233
8820-5808
+86 13396860566
order@pharm-intermediates.com
QQ chat
Chemical manufacturer since 2011
chemBlink standard supplier since 2009
Glentham Life Sciences UK Inquire  
+44 (2033) 978-798
info@glenthamls.com
Chemical distributor since 2013
chemBlink standard supplier since 2013
Axon MedChem BV Netherlands Inquire  
+31 (50) 311-8007
order@axonmedchem.com
Chemical manufacturer
Tocris Bioscience Inc. USA Inquire  
+1 (636) 207-7651
customerservice.na@bio-techne.com
Chemical manufacturer since 1982
Complete supplier list of N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide
Identification
Classification Biochemical >> Inhibitor >> Protein tyrosine kinase
Name N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide
Molecular Structure CAS # 219766-25-3, N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide
Molecular Formula C22H21N3O3S
Molecular Weight 407.49
CAS Registry Number 219766-25-3
EC Number 803-090-7
Properties
Solubility Insoluble (1.8E-3 g/L) (25 ºC), Calc.*
Density 1.36±0.1 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2015 ACD/Labs)
Safety Data
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
SDS Available
Market Analysis Reports
List of Reports Available for N-[2-[[(Hexahydro-2-oxo-1H-azepin-3-yl)amino]carbonyl]phenyl]benzo[b]thiophene-2-carboxamide
Related Products
Hexahydro-1,4,5-oxadiazepine dihydrochloride  Hexahydro-1,4-oxazepine-2-carboxylic acid hydrochloride  Hexahydro-1,4-oxazepine-2-methanol hydrochloride  Hexahydro-1,4-oxazepin-6-ol  Hexahydro-1,4-oxazepin-6-ol  3,5,6,7,8,9-Hexahydro-2H-oxazolo[3,2-a]azepinium tetrafluoroborate(1-)  (3aR,4S,7R,7aS)-Hexahydro-2-[[(1R,2R)-2-[[4-(1-oxido-1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]-4,7-methano-1H-isoindole-1,3(2H)-dione  rel-(1aR,2aS,5aS,5bS)-Hexahydro-4H-oxireno[3,4]cyclopenta[1,2-b]furan-4-one  [1aS-(1aalpha,2aalpha,5aalpha,5balpha)]-Hexahydro-4H-oxireno[3,4]cyclopenta[1,2-b]furan-4-one  Hexahydro-5-oxo-1H-azepine-4-carboxylic acid ethyl ester hydrochloride  N-(Hexahydro-2-oxo-1H-azepin-3-yl)carbamic acid tert-butyl ester  [(3S)-Hexahydro-2-oxo-1H-azepin-3-yl]carbamic acid tert-butyl ester  Hexahydro-5-oxocyclopenta[c]pyrrole-2(1H)-carboxylic acid benzyl ester  4-(Hexahydro-5-oxo-1H-1,4-diazepin-1-yl)-1-piperidinecarboxylic acid tert-butyl ester  (3aS,4S,6aR)-Hexahydro-2-oxo-N-(15-oxo-3,6,9,12-tetraoxa-16-azanonadec-18-yn-1-yl)-1H-thieno[3,4-d]imidazole-4-pentanamide  Hexahydro-5-oxo-1-(phenylmethyl)-1H-azepine-4-carboxylic acid ethyl ester  (3aR,4R,6R,7aS)-Hexahydro-2-oxo-6-(phenylthio)-4-[(1R,2R)-1,2,3-trihydroxypropyl]-4H-pyrano[3,4-d]oxazole-6-carboxylic acid methyl ester  1,2,3,4,5,7-Hexahydro-3-oxo-6H-pyrazolo[3,4-c]pyridine-6-carboxylic acid 1,1-dimethylethyl ester  2,3,5,6,8,9-Hexahydro-3-oxo-7H-pyridazino[3,4-d]azepine-7-carboxylic acid ethyl ester  N-[6-[[4-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-1-oxobutyl]amino]-1-oxohexyl]-L-alpha-aspartyl-L-alanyl-L-alpha-glutamyl-L-phenylalanyl-L-arginyl-L-histidyl-L-alpha-aspartyl-L-serylglycyl-L-tyrosyl-L-alpha-glutamyl-L-valyl-L-histidyl-L-histidyl-L-glutaminyl-L-lysyl-L-leucyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-alanyl-L-alpha-glutamyl-L-alpha-aspartyl-L-valylglycyl-L-seryl-L-asparaginyl-L-lysylglycyl-L-alanyl-L-isoleucyl-L-isoleucylglycyl-L-leucyl-L-methionyl-L-valylglycylglycyl-L-valyl-L-valyl-L-isoleucyl-L-alanine